Concepedia

Andrew W. Pawluczkowycz

AW

Statistics

Publications

9

Citations

934

H-Index

9

Active since

2005

Affiliations

University of Virginia(Current)

Laboratory of Molecular Genetics

University Medical Center Utrecht

Andrew W. Pawluczkowycz is an author at University of Virginia specializing in immunology, immunotherapy, and cancer immunotherapy.

Publications per year

2005–2010

9

Publications

9

Binding of Submaximal C1q Promotes Complement-Dependent Cytotoxicity (CDC) of B Cells Opsonized with Anti-CD20 mAbs Ofatumumab (OFA) or Rituximab (RTX): Considerably Higher Levels of CDC Are Induced by OFA than by RTX

Andrew W. Pawluczkowycz, Frank J. Beurskens, Paul V. Beum et al. · The Journal of Immunology · 2009 · 257 citations · Full text

, , +17

Thrice-Weekly Low-Dose Rituximab Decreases CD20 Loss via Shaving and Promotes Enhanced Targeting in Chronic Lymphocytic Leukemia

Michael E. Williams, John Densmore, Andrew W. Pawluczkowycz et al. · The Journal of Immunology · 2006 · 148 citations · Full text

, , +9

Complement Activation on B Lymphocytes Opsonized with Rituximab or Ofatumumab Produces Substantial Changes in Membrane Structure Preceding Cell Lysis

Paul V. Beum, Margaret A. Lindorfer, Frank J. Beurskens et al. · The Journal of Immunology · 2008 · 125 citations · Full text

, , +17

Binding of Rituximab, Trastuzumab, Cetuximab, or mAb T101 to Cancer Cells Promotes Trogocytosis Mediated by THP-1 Cells and Monocytes

Paul V. Beum, David A. Mack, Andrew W. Pawluczkowycz et al. · The Journal of Immunology · 2008 · 91 citations · Full text

, , +12

Hematin Promotes Complement Alternative Pathway-Mediated Deposition of C3 Activation Fragments on Human Erythrocytes: Potential Implications for the Pathogenesis of Anemia in Malaria

Andrew W. Pawluczkowycz, Margaret A. Lindorfer, John Waitumbi et al. · The Journal of Immunology · 2007 · 87 citations · Full text

, , +16

1–5 of 9